O-linked glycosylation in the mammary gland: Changes that occur during malignancy

Journal of Mammary Gland Biology and Neoplasia

Volumn 6, Issue 3, 2001, Pages 355-364

  Burchell, Joy M ^a   Mungul, Arron ^a   Taylor Papadimitriou, Joyce ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Carbohydrate epitopes; Glycosyltransferases; Mucins; O linked glycosylation

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CYCLOPHOSPHAMIDE; EPITOPE; GLYCAN; GLYCOLIPID; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; KEYHOLE LIMPET HEMOCYANIN; MUCIN; MUCIN 1; PHOSPHORYL LIPID A; SIALOGLYCOPROTEIN; SIALYL N ACETYLGALACTOSAMINE; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARBOHYDRATE ANALYSIS; CLINICAL TRIAL; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LACTATION; LOW DRUG DOSE; MOLECULAR CLONING; NONHUMAN; PREGNANCY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; SIDE EFFECT; TANDEM REPEAT; ANIMAL; BREAST; BREAST TUMOR; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GLYCOSYLATION; METABOLISM; REVIEW;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MUCINS;

EID: 0035405258     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011331809881     Document Type: Article

References (58)

1. J. Taylor-Papadimitriou and J. M. Burchell (1999). O-glycosylation. In T. Creighton (ed.), Encyclopedia of Molecular Biolog, John Wiley & Sons, Inc., London, pp. 1047-1051.
2. F. I. Comer and G. W. Hart (2000). O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J. Biol. Chem. 275:29179-29182.
3. S. Hakomori (1989). Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 52:257-331.
4. M. Granovsky, J. Fata, J. Pawling, W. J. Muller, R. Khokha, and J. W. Dennis (2000). Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6:306-312.
5. S. R. Hull, A. Bright, K. L. Carraway, M. Abe, D. F. Hayes, and D. W. Kufe (1989). Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun. 1:261-267.
6. K. O. Lloyd, J. Burchell, V. Kudryashov, B. W. T. Yin, and J. Taylor-Papadimitriou (1996). Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 271:33325-33334.
7. S. A. Brooks (2000). The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol. Histopathol. 15:143-158.
8. J. M. Burchell, H. Durbin, and J. Taylor-Papadimitriou (1983). Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J. Immunol. 131:508-513.
9. J. M. Burchell, S. Gendler, J. Taylor-Papadimitriou, A. Girling, A. Lewis, R. Millis, and D. Lamport (1987). Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47:5476-5482.
10. A. Girling, J. Bartkova, J. Burchell, S. Gendler, C. Gillett, and J. Taylor-Papadimitriou (1989). A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer 43:1072-1076.
11. J. M. Burchell, R. Poulsom, A. Hanby, C. Whitehouse, L. Cooper, H. Clausen, D. Miles, and J. Taylor-Papadimitriou (1999). An alpha2,3 sialyltransferase (ST3Gal 1) is elevated in primary breast carcinomas. Glycobiology 9:1307-1311.
12. M. Dalziel, C. Whitehouse, I. McFarlane, I. Brockhausen, S. Gschmeissner, T. Schwientek, H. Clausen, J. Burchell, and J. Taylor-Papadimitriou (2001). The relative activities of the C2GnT1 and ST3GalI glycosyltransferases determine O-glycan structure and expression of a tumour-associated epitope on MUC1. J. Biol. Chem. 276: 1007-11015.
13. K. Ryuko, D. J. Schol, F. G. Snijdewint, S. von Mensdorff-Pouilly, R. J. Poort-Keesom, Y. A. Karuntu-Wanamarta, R. A. Verstraeten, K. Miyazaki, P. Kenemans, and J. Hilgers (2000). Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1. Tumour Biol. 21:197-210.
14. H. Clausen and E. P. Bennett (1996). A. family of UDP-GalNAc: Polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology 6:635-646.
15. K. Nehrke, F. K. Hagen, and L. A. Tabak (1998). Isoform-specific O-glycosylation by murine UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferase-T3, in vivo. Glycobiology 8: 67-371.
16. H. H. Wandall, H. Hassan, E. Mirgorodskaya, A. K. Kristensen, P. Roepstorff, E. P. Bennett, P. A. Nielsen, M. A. Hollingsworth, J. Burchell, J. Taylor-Papadimitriou, and H. Clausen (1997). Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J. Biol. Chem. 272:23503-23514.
17. I. Brockhausen, G. Moller, G. Merz, K. Adermann, and H. Paulsen (1990). Control of mucin synthesis: The peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose: N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase. Biochemistry 29:10206-10212.
18. K. Nehrke, F. K. Hagen, and L. A. Tabak (1996). Charge distribution of flanking amino acids influences O-glycan acquisition in vivo. J. Biol. Chem. 271:7061-7065.
19. K. Nehrke, K. G. Ten Hagen, F. K. Hagen, and L. A. Tabak (1997). Charge distribution of flanking amino acids inhibits O-glycosylation of several single-site acceptors in vivo. Glycobiology 7: 053-1060.
20. S. Rottger, J. White, H. H. Wandall, J. C. Olivo, A. Stark, E. P. Bennett, C. Whitehouse, E. G. Berger, H. Clausen, and T. Nilsson (1998). Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J. Cell Sci. 111:45-60.
21. I. Brockhausen, J. M. Yang, J. Burchell, C. Whitehouse, and J. Taylor-Papadimitriou (1995). Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem. 233: 07-617.
22. S. J. Gendler, C. A. Lancaster, J. Taylor-Papadimitriou, T. Duhig, N. Peat, J. Burchell, L. Pemberton, E. N. Lalani, and D. Wilson (1990). Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265:15286-15293.
23. E. P. Bennett, H. Hassan, U. Mandel, E. Mirgorodskaya, P. Roepstorff, J. Burchell, J. Taylor-Papadimitriou, M. A. Hollingsworth, G. Merkx, A. G. van Kessel, H. Eiberg, R. Steffensen, and H. Clausen (1998). Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine: Polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J. Biol. Chem. 273:30472-30481.
24. E. P. Bennett, H. Hassan, U. Mandel, M. A. Hollingsworth, N. Akisawa, Y. Ikematsu, G. Merkx, A. G. van Kessel, S. Olofsson, and H. Clausen (1999). Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J. Biol. Chem. 274: 5362-25370.
25. E. P. Bennett, H. Hassan, M. A. Hollingsworth, and H. Clausen (1999). A novel human UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett. 460: 26-230.
26. T. White, E. P. Bennett, K. Takio, T. Sorensen, N. Bonding, and H. Clausen (1995). Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase. J. Biol. Chem. 270: 4156-24165.
27. H. Hassan, C. A. Reis, E. P. Bennett, E. Mirgorodskaya, P. Roepstorff, M. A. Hollingsworth, J. Burchell, J. Taylor-Papadimitriou, and H. Clausen (2000). The lectin domain of UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities. J. Biol. Chem. 275:38197-38205.
28. S. Muller, S. Goletz, N. Packer, A. Gooley, A. M. Lawson, and F. G. Hanisch (1997). Localization of O-glycosylation sites on glycopeptide fragments from lactation -associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo. J. Biol. Chem. 272:24780-24793.
29. S. Muller, K. Alving, J. Peter-Katalinic, N. Zachara, A. A. Gooley, and F. G. Hanisch (1999). High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells. J. Biol. Chem. 274:18165-18172.
30. F.-G. Hanisch (2000). O-glycosylation of human MUC-1: Site specificity, biosynthetic regulation and immunological implications. In 12th Joint Meeting, Villeneuve d'Ascq, Lille, France, p. 14.
31. M. F. Bierhuizen and M. Fukuda (1992). Expression cloning of a cDNA encoding UDP-GlcNAc:GAl beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc. Natl. Acad. Sci. U.S.A. 89: 326-9330.
32. A. Tsuchiya, M. Kanno, T. Kawaguchi, Y. Endo, G. J. Zhang, T. Ohtake, and I. Kimijima (1999). Prognostic Relevance of Tn Expression in Breast Cancer. Breast Cancer 6:175-180.
33. T. Schwientek, J. C. Yeh, S. B. Levery, B. Keck, G. Merkx, A. G. van Kessel, M. Fukuda, and H. Clausen (2000). Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n-acetylglucosaminyltransferase. J. Biol. Chem. 275:11106-11113.
34. J. C. Yeh, E. Ong, and M. Fukuda (1999). Molecular cloning and expression of a novel beta-1 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches. J. Biol. Chem. 274:3215-3221.
35. T. Schwientek, M. Nomoto, S. B. Levery, G. Merkx, A. G. van Kessel, E. P. Bennett, M. A. Hollingsworth, and H. Clausen (1999). Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. J. Biol. Chem. 274:4504-4512.
36. F.-G. Hanisch, G. Uhlenbruck, J. Peter-Katalinic, H. Egge, J. Dabrowski, and U. Dabrowski (1989). Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyllactosamine backbones with Gal beta(1-4)GlcNAc beta(1-6) repeating units. J. Biol. Chem. 264: 72-883.
37. F-G. Hanisch, J. Peter-Katalinic, H. Egge, U. Dabrowski, and G. Uhlenbruck (1990). Structures of acidic O-linked polylactosaminoglycans on human skim milk mucins. Glycoconj. J. 7:525-543.
38. G. F. Springer, W. A. Fry, P. R. Desai, R. A. Semerdjian, H. Tegtmeyer, C. G. Neybert, and E. F. Scanlon (1985). Further studies on the detection of early lung and breast carcinoma by T antigen. Cancer Detect. Prev. 8:95-100.
39. T. Nakagoe, T. Sawai, T. Tsuji, M. Jibiki, M. Ohbatake, A. Nanashima, H. Yamaguchi, T. Yasutake, H. Ayabe, and K. Arisawa (2000). Prognostic Value of Serum Sialyl Lewis(a), Sialyl Lewis(x) and Sialyl Tn Antigens in Blood from the Tumor Drainage Vein of Colorectal Cancer Patients Tumour Biol. 22:115-122.
40. R. Soares, A. Marinho, and F. Schmitt (1996). Expression of sialyl-Tn in breast cancer. Correlation with prognostic parameters. Pathol. Res. Pract. 192:1181-1186.
41. D. W. Miles, L. C. Happerfield, P. Smith, R. Gillibrand, L. G. Bobrow, W. M. Gregory, and R. D. Rubens (1994). Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br. J. Cancer 70:1272-1275.
42. Y. Ura, A. S. Dion, C. J. Williams, B. D. Olsen, E. S. Redfield, M. Ishida, M. Herlyn, and P. P. Major (1992). Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues. Int. J. Cancer 50:57-63.
43. T. Narita, H. Funahashi, Y. Satoh, T. Watanabe, J. Sakamoto, and H. Takagi (1993). Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer 71:3044-3053.
44. R. Sikut, K. Zhang, D. Baeckstrom, and G. C. Hansson (1996). Distinct subpopulations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients. Int. J. Cancer 66:617-623.
45. M. Demetriou, I. R. Nabi, M. Coppolino, S. Dedhar, and J. W. Dennis (1995). Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 130:383-392.
46. Y. Ikehara, N. Kojima, N. Kurosawa, T. Kudo, M. Kono, S. Nishihara, S. Issiki, K. Morozumi, S. Itzkowitz, T. Tsuda, S. I. Nishimura, S. Tsuji, and H. Narimatsu (1999). Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAcI): A candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology 9:1213-1224.
47. M. A. Recchi, M. Hebbar, L. Hornez, A. Harduin-Lepers, J. P. Peyrat, and P. Delannoy (1998). Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 58:4066-4070.
48. C. Whitehouse, J. Burchell, S. Gschmeissner, I. Brockhausen, K. O. Lloyd, and J. Taylor-Papadimitriou (1997). A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans. J. Cell Biol. 137:1229-1241.
49. K. L. Carraway, S. A. Price-Schiavi, M. Komatsu, N. Idris, A. Perez, P. Li, S. Jepson, X. Zhu, M. E. Carvajal, and C. A. Carraway (2000). Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). Front. Biosci. 5: 95-D107.
50. J. P. Peyrat, M. A. Recchi, M. Hebbar, V. Pawlowski, L. Hornez, X. Dong-Lebouhris, H. Hondermarck, A. Harduin-Lepers, and P. Delannoy (2000). Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7. Mol. Cell Biol. Res. Commun. 3:48-52.
51. S. von Mensdorff-Pouilly, E. Petrakou, P. Kenemans, K. van Uffelen, A. A. Verstraeten, F. G. Snijdewint, G. J. van Kamp, D. J. Schol, C. A. Reis, M. R. Price, P. O. Livingston, and J. Hilgers (2000). Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int. J. Cancer 86: 02-712.
52. L. J. Sigal, S. Crotty, R. Andino, and K. L. Rock (1999). Cytotoxic T-cell immunity to virus-infected nonhaematopoietic cells requires presentation of exogenous antigen. Nature 398:77-80.
53. L. Galli-Stampino, E. Meinjohanns, K. Frische, M. Meldal, T. Jensen, O. Werdelin, and S. Mouritsen (1997). T-cell recognition of tumor-associated carbohydrates: The nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res. 57: 214-3222.
54. R. Medzhitov and C. A. Janeway, Jr. (1997). Innate immunity: The virtues of a nonclonal system of recognition. Cell 91: 95-298.
55. P. Y. Fung, M. Madej, R. R. Koganty, and B. M. Longenecker (1990). Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res. 50: 308-4314.
56. A. Singhal, M. Fohn, and S. Hakomori (1991). Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res. 51:1406-1411.
57. G. D. MacLean, D. W. Miles, R. D. Rubens, M. A. Reddish, and B. M. Longenecker (1996). Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide. J. Immunother. Emphasis Tumor Immunol. 19:309-316.
58. P. Y. Fung and B. M. Longenecker (1991). Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA). Cancer Res. 51:1170-1176.